Active ingredient
Cisatracurium besylate NDC Codes
Cisatracurium besylate is an active ingredient in 41 finished products listed with the FDA, under 2 names.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Brand and generic names
- Cisatracurium Besylate, Cisatracurium
- Labelers
- Meitheal Pharmaceuticals Inc., Camber Pharmaceuticals Inc., Gland Pharma Limited, Hikma Pharmaceuticals USA Inc., Caplin Steriles Limited, Slate Run Pharmaceuticals, LLC, Hospira, Inc., Somerset Therapeutics, LLC, Fresenius Kabi USA, LLC, Sandoz Inc
- Strengths
- Cisatracurium besylate 2 mg/mL; Cisatracurium besylate 10 mg/mL; Cisatracurium besylate 200 mg/20mL; Cisatracurium besylate 10 mg/5mL; Cisatracurium besylate 20 mg/10mL
- Dosage forms
- Injection, Injection, Solution
- Routes
- Intravenous
- Drug classes (FDA established)
- Nondepolarizing Neuromuscular Blocker
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 46
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|---|
| Cisatracurium Besylate | Cisatracurium besylate 10 mg/mL | Injection, SolutionIntravenous | Avenacy, LLC | 83634-655 | 83634-0655-20 | — |
| Cisatracurium Besylate | Cisatracurium besylate 10 mg/mL | InjectionIntravenous | Camber Pharmaceuticals Inc. | 31722-312 | 31722-0312-10 | — |
| Cisatracurium Besylate | Cisatracurium besylate 2 mg/mL | InjectionIntravenous | Camber Pharmaceuticals Inc. | 31722-313 | 31722-0313-10 | — |
| Cisatracurium Besylate | Cisatracurium besylate 2 mg/mL | InjectionIntravenous | Camber Pharmaceuticals Inc. | 31722-314 | 31722-0314-10 | — |
| Cisatracurium besylate | Cisatracurium besylate 2 mg/mL | InjectionIntravenous | Gland Pharma Limited | 68083-486 | 68083-0486-01 | — |
| Cisatracurium besylate | Cisatracurium besylate 10 mg/mL | InjectionIntravenous | Gland Pharma Limited | 68083-487 | 68083-0487-01 | — |
| Cisatracurium besylate | Cisatracurium besylate 2 mg/mL | InjectionIntravenous | Gland Pharma Limited | 68083-488 | 68083-0488-01 | — |
| Cisatracurium Besylate | Cisatracurium besylate 2 mg/mL | InjectionIntravenous | Hikma Pharmaceuticals USA Inc. | 0143-9397 | 00143-9397-10 | — |
| Cisatracurium Besylate | Cisatracurium besylate 10 mg/mL | InjectionIntravenous | Hikma Pharmaceuticals USA Inc. | 0143-9160 | 00143-9160-10 | — |
| Cisatracurium besylate | Cisatracurium besylate 2 mg/mL | InjectionIntravenous | Caplin Steriles Limited | 65145-135 | 65145-0135-0165145-0135-10 | — |
| Cisatracurium besylate | Cisatracurium besylate 2 mg/mL | InjectionIntravenous | Caplin Steriles Limited | 65145-136 | 65145-0136-0165145-0136-10 | — |
| Cisatracurium besylate | Cisatracurium besylate 10 mg/mL | InjectionIntravenous | Caplin Steriles Limited | 65145-137 | 65145-0137-01 | — |
| Cisatracurium Besylate | Cisatracurium besylate 200 mg/20mL | InjectionIntravenous | Armas Pharmaceuticals | 72485-513 | 72485-0513-10 | — |
| Cisatracurium besylate | Cisatracurium besylate 2 mg/mL | InjectionIntravenous | Slate Run Pharmaceuticals, LLC | 70436-113 | 70436-0113-82 | — |
| Cisatracurium Besylate | Cisatracurium besylate 2 mg/mL | InjectionIntravenous | Hikma Pharmaceuticals USA Inc. | 0143-9396 | 00143-9396-01 | — |
| Cisatracurium besylate | Cisatracurium besylate 2 mg/mL | InjectionIntravenous | Slate Run Pharmaceuticals, LLC | 70436-112 | 70436-0112-82 | — |
| Cisatracurium besylate | Cisatracurium besylate 10 mg/mL | InjectionIntravenous | Slate Run Pharmaceuticals, LLC | 70436-114 | 70436-0114-82 | — |
| Cisatracurium Besylate | Cisatracurium besylate 10 mg/5mL | InjectionIntravenous | Eugia US LLC | 55150-284 | 55150-0284-10 | — |
| Cisatracurium Besylate | Cisatracurium besylate 20 mg/10mL | InjectionIntravenous | Eugia US LLC | 55150-286 | 55150-0286-10 | — |
| Cisatracurium Besylate | Cisatracurium besylate 2 mg/mL | Injection, SolutionIntravenous | Hospira, Inc. | 0409-1208 | 00409-1208-01 | — |
| Cisatracurium Besylate | Cisatracurium besylate 2 mg/mL | Injection, SolutionIntravenous | Hospira, Inc. | 0409-1098 | 00409-1098-02 | — |
| cisatracurium besylate | Cisatracurium besylate 2 mg/mL | InjectionIntravenous | Zydus Lifesciences Limited | 72785-0008 | 72785-0008-06 | — |
| cisatracurium besylate | Cisatracurium besylate 10 mg/mL | InjectionIntravenous | Zydus Lifesciences Limited | 72785-0009 | 72785-0009-06 | — |
| cisatracurium besylate | Cisatracurium besylate 2 mg/mL | InjectionIntravenous | Zydus Pharmaceuticals USA Inc. | 70710-1532 | 70710-1532-06 | — |
| cisatracurium besylate | Cisatracurium besylate 10 mg/mL | InjectionIntravenous | Zydus Pharmaceuticals USA Inc. | 70710-1534 | 70710-1534-06 | — |
| Cisatracurium Besylate | Cisatracurium besylate 10 mg/mL | Injection, SolutionIntravenous | Hospira, Inc. | 0409-1103 | 00409-1103-01 | — |
| Cisatracurium Besylate | Cisatracurium besylate 10 mg/5mL | Injection, SolutionIntravenous | Meitheal Pharmaceuticals Inc. | 71288-712 | 71288-0712-96 | — |
| Cisatracurium Besylate | Cisatracurium besylate 10 mg/5mL | Injection, SolutionIntravenous | Meitheal Pharmaceuticals Inc. | 71288-712 | 71288-0712-06 | — |
| Cisatracurium Besylate | Cisatracurium besylate 200 mg/20mL | Injection, SolutionIntravenous | Meitheal Pharmaceuticals Inc. | 71288-713 | 71288-0713-96 | — |
| Cisatracurium Besylate | Cisatracurium besylate 200 mg/20mL | Injection, SolutionIntravenous | Meitheal Pharmaceuticals Inc. | 71288-713 | 71288-0713-21 | — |
| Cisatracurium Besylate | Cisatracurium besylate 20 mg/10mL | Injection, SolutionIntravenous | Meitheal Pharmaceuticals Inc. | 71288-714 | 71288-0714-96 | — |
| Cisatracurium Besylate | Cisatracurium besylate 20 mg/10mL | Injection, SolutionIntravenous | Meitheal Pharmaceuticals Inc. | 71288-714 | 71288-0714-11 | — |
| Cisatracurium Besylate | Cisatracurium besylate 2 mg/mL | InjectionIntravenous | Somerset Therapeutics, LLC | 70069-161 | 70069-0161-0170069-0161-10 | — |
| Cisatracurium Besylate | Cisatracurium besylate 2 mg/mL | InjectionIntravenous | Somerset Therapeutics, LLC | 70069-141 | 70069-0141-0170069-0141-10 | — |
| Cisatracurium Besylate | Cisatracurium besylate 10 mg/mL | InjectionIntravenous | Somerset Therapeutics, LLC | 70069-151 | 70069-0151-0170069-0151-10 | — |
| Cisatracuriumcisatracurium besylate | Cisatracurium besylate 2 mg/mL | Injection, SolutionIntravenous | Fresenius Kabi USA, LLC | 63323-416 | 63323-0416-05 | — |
| Cisatracuriumcisatracurium besylate | Cisatracurium besylate 2 mg/mL | Injection, SolutionIntravenous | Fresenius Kabi USA, LLC | 63323-417 | 63323-0417-10 | — |
| Cisatracuriumcisatracurium besylate | Cisatracurium besylate 10 mg/mL | Injection, SolutionIntravenous | Fresenius Kabi USA, LLC | 63323-418 | 63323-0418-20 | — |
| cisatracurium besylate | Cisatracurium besylate 2 mg/mL | InjectionIntravenous | Sandoz Inc | 0781-3150 | 00781-3150-95 | — |
| cisatracurium besylate | Cisatracurium besylate 2 mg/mL | InjectionIntravenous | Sandoz Inc | 0781-3152 | 00781-3152-95 | — |
| cisatracurium besylate | Cisatracurium besylate 10 mg/mL | InjectionIntravenous | Sandoz Inc | 0781-3153 | 00781-3153-95 | — |
Cisatracurium besylate: common questions
- Which drugs contain Cisatracurium besylate?
- Cisatracurium Besylate, Cisatracurium.
- Is there a J-code for Cisatracurium besylate?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.